ABPath Medical Microbiology common mistakes
ABPath Medical Microbiology · Understand the traps and how to avoid them.
Selecting a biosafety level (BSL) for a procedure based only on the organism's risk group rather than on the risk assessment of the specific procedure (e.g., performing a high-concentration aerosol-generating manipulation of a BSL-2 organism at BSL-2).
Candidates memorize organism-to-BSL tables and treat them as one-to-one, forgetting that BSL is assigned to practices and procedures, not just species.
What to do instead
Practice answering safety items by explicitly naming the manipulation (centrifugation, vortexing, subculturing on open bench) and asking whether aerosols are generated; state that risk assessment drives the required containment and that a higher BSL may be required for a BSL-2 organism.
Confusing the roles of CLIA complexity categories with test accreditation, e.g., labeling a test 'waived' because it is FDA-cleared or assuming a moderate-complexity lab may perform any high-complexity method.
The regulatory framework (CLIA certificate types, test complexity, personnel requirements) is memorized as isolated facts without a working model of how they interlock.
What to do instead
Build a one-page matrix linking certificate type (waived, moderate, high complexity) to permitted tests and required personnel; answer regulatory items by first identifying the certificate type implied by the scenario.
Treating a single out-of-range QC result as automatically invalidating patient results, or conversely releasing patient results when QC failed and no corrective action is documented.
Candidates learn Westgard rules and QC statistics separately from the operational decision algorithm for handling a QC failure.
What to do instead
Use a fixed sequence for every QC-failure item: stop testing, identify the rule violated, troubleshoot (reagent, calibration, control, instrument), repeat control, document, and only then decide on patient result review; state the sequence explicitly in the answer.
Misapplying the 1:10 rule for out-of-range QC, or failing to recognize when a QC rule signals random versus systematic error.
The numeric rule and the error-type classification are learned as trivia rather than as decision tools.
What to do instead
Memorize that a single control exceeding ±2SD but within ±3SD triggers the 1:2s warning and requires another control within 1:4s/10x before rejection; link 1:3s and 2:2s to random error and 4:1s, 10x, and trend rules to systematic error.
Assigning an organism to the wrong taxonomic rank or using a superseded or incorrectly formatted name (e.g., capitalizing a species epithet, italicizing a family name, or using an old genus name).
Nomenclature conventions (ICNP) are learned casually, and taxonomy updates are not tracked.
What to do instead
Apply the formatting rules mechanically: genus and species italicized with only genus capitalized, family and higher taxa capitalized but not italicized, and check current valid names (e.g., Klebsiella aerogenes rather than Enterobacter aerogenes) before finalizing.
Accepting a specimen that is inappropriate for the suspected diagnosis (e.g., a swab instead of sputum for mycobacteriology, or a superficial swab for a deep wound) and then interpreting the negative result as meaningful.
Candidates focus on the organism and the test method while overlooking specimen adequacy and site-of-infection matching.
What to do instead
For every specimen item, first ask whether the collection site and device can recover the target organism; reject or comment on inadequate specimens (saliva, dry swabs, delayed transport) and state the preferred specimen type before discussing the test.
Attributing a positive culture to infection without distinguishing colonization, contamination, and true infection (e.g., a single sputum culture growing Candida, or a single blood culture growing a coagulase-negative staphylococcus).
Candidates equate organism detection with disease and skip the host, site, and quantity context.
What to do instead
For each positive-culture scenario, explicitly weigh quantity, purity, host immune status, and presence of inflammation; state that a single culture bottle with a skin commensal usually represents contamination and recommend repeat cultures before therapy.
Reporting an antimicrobial susceptibility result without applying the correct interpretation context, such as using a breakpoint for the wrong specimen source, ignoring intrinsic resistance, or misinterpreting inducible resistance (e.g., reporting clindamycin susceptible for an erythromycin-resistant, D-test-positive staphylococcus).
Candidates memorize breakpoint numbers but not the rules governing when a result is reportable or how to detect inducible or intrinsic resistance.
What to do instead
Before finalizing any susceptibility answer, check intrinsic resistance for the organism, apply the D-test when erythromycin is resistant and clindamycin is tested, and confirm that the breakpoint matches the organism, drug, and specimen source.
Confusing the purpose of selective, differential, and enriched media, or misreading a key reaction (e.g., interpreting a black precipitate on a bile-esculin plate as a positive esculin reaction rather than as evidence of esculin hydrolysis with iron, or confusing lactose fermentation with H2S production on a differential medium).
Media composition and indicator chemistry are memorized as lists rather than as cause-and-effect mechanisms.
What to do instead
For each medium, write the inhibitory agent, the differential substrate, the indicator, and the visible result that signals a positive reaction; practice predicting the appearance of a known organism on each medium before answering.
Choosing a diagnostic method without matching it to the clinical question, e.g., ordering serology for acute bacterial infection where culture or nucleic acid amplification is needed, or relying on a single negative molecular test to exclude infection without considering sensitivity and pretest probability.
Candidates treat test categories as interchangeable and ignore sensitivity, specificity, and the window period of the assay.
What to do instead
For method-selection items, state the target (organism, antigen, antibody, nucleic acid), the expected time course of the marker, and the assay's limitations; recommend the test whose sensitivity and turn-around time fit the clinical decision being made.
Recommending antimicrobial therapy or additional testing without integrating the laboratory result into the patient's clinical picture (e.g., treating a positive urine culture in an asymptomatic patient, or failing to recommend susceptibility testing when resistance is likely).
Candidates answer the microbiology question in isolation and skip the consultation step of translating a result into a patient-care recommendation.
What to do instead
End every consultation-style item with an explicit recommendation that names the clinical context, the significance of the result, and the next laboratory or therapeutic step, and flag when the result should not drive treatment.